<?xml version="1.0" encoding="ISO-8859-1" ?>
	<rss xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
	<channel>
	<title>Respiratory diseases Market Research</title>
	<description>Last published market research from plusdetudes.com related to
	Respiratory diseases.</description>
	<link>http://www.plusdetudes.com/ci0235/-market-research.html</link>
	<dc:date>2007-08-21T12:45:16Z</dc:date><item>
		<title>Discovery Laboratories Inc - SWOT Analysis - [2007-07-13]</title>
		<description>Datamonitor's Discovery Laboratories Inc - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides s</description>
		<link>http://www.plusdetudes.com/p054606/Discovery-Laboratories-Inc-SWOT-Analysis.html</link>
		<guid>http://www.plusdetudes.com/p054606/Discovery-Laboratories-Inc-SWOT-Analysis.html</guid></item>
<item>
		<title>InterMune Inc. - SWOT Analysis - [2007-07-13]</title>
		<description>Datamonitor's InterMune Inc. - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analy</description>
		<link>http://www.plusdetudes.com/p054601/InterMune-Inc-SWOT-Analysis.html</link>
		<guid>http://www.plusdetudes.com/p054601/InterMune-Inc-SWOT-Analysis.html</guid></item>
<item>
		<title>Commercial Insight: Asthma and COPD - Combination products still have blockbuster potential - [2007-07-11]</title>
		<description>IntroductionDetailed analysis of the Asthma and COPD market. 10 year sales forecast for all major drugs brands in these indications, taking into account new treatment trends, clinical trial data, patent expirations and key new product launche</description>
		<link>http://www.plusdetudes.com/p054276/Commercial-Insight-Asthma-and-COPD-Combination-products-still-have-blockbuster-potential.html</link>
		<guid>http://www.plusdetudes.com/p054276/Commercial-Insight-Asthma-and-COPD-Combination-products-still-have-blockbuster-potential.html</guid></item>
<item>
		<title>Pulmonary Drug Delivery Technologies - [2007-06-01]</title>
		<description>This report analyzes the worldwide markets for Pulmonary Drug Delivery Technologies in Millions of US$. The specific product segments analyzed are Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs) and Nebulizers. The report provides separate c</description>
		<link>http://www.plusdetudes.com/p053735/Pulmonary-Drug-Delivery-Technologies.html</link>
		<guid>http://www.plusdetudes.com/p053735/Pulmonary-Drug-Delivery-Technologies.html</guid></item>
<item>
		<title>AstraZeneca PLC - SWOT Analysis - [2007-05-25]</title>
		<description>Datamonitor's AstraZeneca PLC - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary anal</description>
		<link>http://www.plusdetudes.com/p050192/AstraZeneca-PLC-SWOT-Analysis.html</link>
		<guid>http://www.plusdetudes.com/p050192/AstraZeneca-PLC-SWOT-Analysis.html</guid></item>
<item>
		<title>Purdue Pharma - SWOT Analysis - [2007-05-24]</title>
		<description>Datamonitor's Purdue Pharma - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analys</description>
		<link>http://www.plusdetudes.com/p050469/Purdue-Pharma-SWOT-Analysis.html</link>
		<guid>http://www.plusdetudes.com/p050469/Purdue-Pharma-SWOT-Analysis.html</guid></item>
<item>
		<title>U.S. Market for Home Care Products, 5th Edition - [2007-05-01]</title>
		<description>This study U.S. Market for Home Care Products, 5th Edition represents the fifth time Kalorama Information has investigated this growing market over the past 12 years.The U.S. market for home care products and equipment continues to post stead</description>
		<link>http://www.plusdetudes.com/p049676/US-Market-for-Home-Care-Products-5th-Edition.html</link>
		<guid>http://www.plusdetudes.com/p049676/US-Market-for-Home-Care-Products-5th-Edition.html</guid></item>
<item>
		<title>Smoking Cessation and Addiction Treatments: A World Market Analysis - [2007-04-01]</title>
		<description>Smoking cessation is an increasingly important area of focus for pharmaceutical companies, healthcare entities and governments. There are 1.4 billion smokers in the world, and with smoking is a known cause of heart disease, lung cancer, respiratory i</description>
		<link>http://www.plusdetudes.com/p049045/Smoking-Cessation-and-Addiction-Treatments-A-World-Market-Analysis.html</link>
		<guid>http://www.plusdetudes.com/p049045/Smoking-Cessation-and-Addiction-Treatments-A-World-Market-Analysis.html</guid></item>
<item>
		<title>Drug Delivery Series I-IV - [2007-04-01]</title>
		<description>This report includes all four volumes of Kalorama's 2nd edition of its Drug Delivery Markets series, covering all major types, including: Oral Delivery Implantable/Injectable Pulmonary Transdermal/Transmucosal Novel pharmacologica</description>
		<link>http://www.plusdetudes.com/p049048/Drug-Delivery-Series-I-IV.html</link>
		<guid>http://www.plusdetudes.com/p049048/Drug-Delivery-Series-I-IV.html</guid></item>
<item>
		<title>Stakeholder Opinions: Asthma Phenotypes  A changing paradigm - [2007-03-26]</title>
		<description>IntroductionAn estimated 34 million people are diagnosed with asthma in the major markets. The disease can be broken down into various phenotypes, differentiated by severity, trigger, or predominant inflammatory type. These phenotypes may hav</description>
		<link>http://www.plusdetudes.com/p047043/Stakeholder-Opinions-Asthma-Phenotypes-A-changing-paradigm.html</link>
		<guid>http://www.plusdetudes.com/p047043/Stakeholder-Opinions-Asthma-Phenotypes-A-changing-paradigm.html</guid></item>
</channel></rss>